Acute coronary syndrome Trials in Winchester, United States
Conditions / Acute coronary syndrome / Winchester, United States
Acute coronary syndrome has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00391872 | A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome | COMPLETED | PHASE3 |
| NCT05918861 | Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS | RECRUITING | PHASE3 |
| NCT05754957 | A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01000727 | The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial | COMPLETED | PHASE3 |
| NCT04873934 | Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome | COMPLETED | PHASE3 |
| NCT01088503 | Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome | COMPLETED | — |
| NCT01076764 | Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy | COMPLETED | PHASE3 |
| NCT02525939 | Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS | COMPLETED | PHASE3 |
| NCT00557921 | Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) | TERMINATED | PHASE3 |
| NCT03473223 | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome | COMPLETED | PHASE3 |